| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Development Officer | See Remarks
1 company
Michaelson Jennifer is a Chief Scientific Officer at Cullinan Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Development Officer | Sell | 238 | $10.71 | $2,548.98 | -0.3% | +10.3% | +74.1% | |
| Apr 12, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Development Officer | Sell | 176 | $10.22 | $1,798.72 | -0.2% | +1.1% | +74.9% | |
| Mar 20, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Development Officer | Sell | 238 | $11.32 | $2,694.16 | -0.3% | +20.1% | +42.5% | |
| Nov 25, 2022 | CGEM Cullinan Therapeutics, Inc. | See Remarks | Sale+OE | 4,000 | $13.30 | $53,200.00 | -7.0% | -17.2% | -34.0% | |
| Sep 27, 2022 | CGEM Cullinan Therapeutics, Inc. | See Remarks | Sale+OE | 4,000 | $12.40 | $49,600.00 | -7.0% | -20.9% | -17.5% | |
| Aug 8, 2022 | CGEM Cullinan Therapeutics, Inc. | Chief Development Officer | Sale+OE | 1,385 | $15.01 | $20,788.85 | -2.5% | -15.3% | -27.1% | |
| Jul 25, 2022 | CGEM Cullinan Therapeutics, Inc. | Chief Development Officer | Sale+OE | 8,000 | $14.51 | $116,080.00 | -13.1% | -15.5% | -29.4% | |
| Oct 18, 2021 | CGEM Cullinan Therapeutics, Inc. | See Remarks | Sale+OE | 4,000 | $21.42 | $85,669.20 | -5.4% | -39.3% | -39.9% | |
| Sep 20, 2021 | CGEM Cullinan Therapeutics, Inc. | See Remarks | Sale+OE | 4,000 | $24.51 | $98,048.00 | -7.9% | -34.8% | -49.8% | |
| Aug 18, 2021 | CGEM Cullinan Therapeutics, Inc. | See Remarks | Sale+OE | 4,000 | $27.66 | $110,648.09 | -7.8% | -23.5% | -50.8% |